在ER中,由压力驱动的未折叠蛋白质反应推动了结质瘤中与衰老相关的瘤攻击性
Xiaodong Shao1, Shaolei Guo1, Jia Yang1
1Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Frontiers in molecular biosciences
|July 28, 2025
概括
衰老和内质网膜 (ER) 压力通过展开的蛋白质反应 (UPR) 驱动质瘤的攻击性. 一种新的六基因特征 (ESURATAG) 预测了不良结果,并为质瘤患者提供了治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 衰老研究研究 衰老研究
背景情况:
- 质瘤是侵袭性的原发性脑瘤,老化显著影响发病率和进展.
- 衰老途径和质瘤的攻击性之间的分子联系还不太清楚.
研究的目的:
- 为了确定与衰老相关的分子机制,驱动瘤在质瘤中的攻击性.
- 开发和验证一种基因特征,用于预测质瘤的攻击性.
主要方法:
- 对TCGA-质瘤患者的数据进行了全面的转录组分析.
- 研究人员将内质网膜 (ER) 应激和未折叠蛋白质反应 (UPR) 作为关键的与衰老相关的机制.
- 验证使用多个独立的GEO数据集进行.
主要成果:
- ER压力和UPR被确定为关键的衰老相关机制在质瘤的攻击性.
- 开发了一个六基因签名 (ESURATAG),包括DERL2,RPN2,SEC13,SEC61A1,SEC61B和STT3A.
- 高ESURATAG表达与疾病进展,MYC调节,炎症和质瘤亚型的低生存率相关.
结论:
- ESURATAG基因特征是一个关键的MYC调节的适应机制,通过ER压力驱动的UPR在结质瘤中推动与衰老相关的瘤攻击性.
- ESURATAG为老年质瘤患者提供了新的预后标志物和潜在的治疗点.
相关概念视频
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K


